Lundbeck US in Deerfield earns top ranking

For the third straight year Deerfield-based Lundbeck US, an affiliate of Danish-based H. Lundbeck, was ranked first in corporate reputation by U.S. patient groups.

According to the annual PatientView Corporate Reputation of Pharma, U.S. Edition, Lundbeck has the best overall reputation among patient groups familiar with the company. Lundbeck also ranked first in 10 individual categories, including patient-centricity and integrity.

"Receiving this recognition is very rewarding; but to receive it three years in a row is particularly meaningful. It is a powerful testament to the dedication our employees have to the patient communities we serve," said Peter Anastasiou, executive vice president and head of Lundbeck North America. "At Lundbeck, we always strive to see the person behind the disease, and we are deeply embedded in our patient communities so that we stay attuned to patients' needs. To know that patient groups recognize and value our commitment and active engagement is both gratifying and inspiring."

The ranking is based on feedback from 169 U.S. patient groups. The groups ranked 30 leading pharmaceutical companies on 12 key reputational attributes: patient-centered strategy, patient information, patient safety, high-quality products, transparency in pricing, transparency in clinical data, transparency in funding, corporate integrity, quality of patient-group relationships, "beyond the pill" services, engaging patients in research and engaging patients in development.